David Weinberg received his Ph.D. from the Johns Hopkins University in 1983 for work on the Adenovirus type 2 early region 4. Following a postdoctoral fellowship, he joined the pharmaceutical company Merck &Co. in 1989. Dr. Weinberg spent the next 2 decades in early stage drug discovery focused on a broad array of targets aimed at the treatment of obesity while gaining experience across all aspects of translational research and preclinical drug development. In 2009, he joined the National Institutes of Health (NIH) as a Health Science Administrator where he managed the review of grant applications across a broad spectrum of scientific topics with particular emphasis in the area of female reproductive research. In 2014, Dr. Weinberg became the Project Lead for NICHD’s newly launched Human Placenta Project. The goal of this project is to accelerate the progress towards safe, non-invasive, real-time assessment of placental structure and function across pregnancy. In 2017, Dr. Weinberg joined the Contraceptive Research Branch where he applies his drug discovery and translational research experience to help promote the branch efforts to facilitate discovery and development of new and improved contraceptive drugs and devices.